Pfizer Inc - PFE Projected Future Earnings

Corporate emblem and logo of Pfizer Corp (PFE)

The price trend shown below illustrates the profit dynamics of Pfizer Inc. (PFE), which stands at 16.87. The business is currently pivoting toward oncology and new assets due to declining vaccine demand. Financial stability relies on a massive drug portfolio and government contracts. Growth is accelerating through strategic alliances with research centers and biotech startups to drive innovation.

Pfizer Inc. (PFE): Expected Net Profit from 07/04/2022 to 11/12/2026

Analytical breakdowns for Pfizer Inc (PFE)

- stock quotes and analyst forecast:
Stock Quotes Pfizer Inc.|PFE - Fair Value Consensus
- issuer market value details:
Market Capitalization Pfizer|PFE - Value Adjusted for Debt and Cash
- book capitalization indicators:
Net Assets per Single Share Pfizer|PFE - Total Stockholders' Equity|Market Value to Book Value Ratio pfizer.com|PFE - Aggregate Company Assets
- company total debt and liquidity indicators:
Total Debt to Capital Pfizer Inc.|PFE - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Pfizer Corporation|PFE - Company Total Debt Obligations|Debt to Book Capitalization Ratio Pfizer|PFE - Company Long-Term Indebtedness|Company Short-Term Debts Pfizer|Quick Liquidity pfizer.com
- net income and valuation ratios data:
PFE - Profit After Tax|Projected Future Earnings Pfizer Inc.|PFE - Market Cap to Net Income|Forward P/E Multiple Pfizer|PFE - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Pfizer|PFE - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) Pfizer|PFE - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months pfizer.com|PFE - Earnings per share increase in current year|Expected earnings per share growth for next year Pfizer Inc.
Initial company analysis:PFE, Pfizer Inc.
Finished products of Pfizer Inc

Projected earnings reflect the calculated business efficiency, stripped of historical distortions and market noise, allowing investors to assess the real potential for yield growth. An analysis of the projected profitability trajectory reveals that the impact of plant automation and the repurposing of Pfizer Inc. (PFE) capacities for oncology projects is reducing costs, which determines the fundamental value of the shares regardless of speculative volatility.

Competing companies

Future Profit LLY|ABBV: Expected Net Income|Projected Future Earnings AZN|NVS (Novartis Corporation) - Expected Net Income|Expected Profit Merck Sharp & Dohme MRK|Novo Nordisk Group (NVO) - Expected Net Profit|AMGN - Expected Profit|SNY: Expected Profit|BMY: Projected Future Earnings|Net Profit Forecast GSK|TAK (Takeda Pharmaceutical Company Limited) - Projected Future Earnings|tevapharm.com (TEVA) - Company Profit Forecast|Expected Profit Dr. Reddy's Laboratories (RDY)|viatris.com - Net Profit Forecast|Projected Future Earnings ROIV (Roivant Sciences)|Projected Net Profit Zai Lab Ltd|BHC - Expected Profit|Forward Earnings COSM